THE MERCK MANUAL OF GERIATRICS, Index C
- Index Index-A -| Index-B -| Index-C -| Index-D -| Index-E -| Index-F -| Index-G -| Index-H -| Index-I -| Index-J &n; bsp;| Index-K -| Index-L -| Index-M -| Index-N -| Index-O -| Index-P -| Index-Q -| Index-R -| Index-S -| Index-T -| Index-U -| Index-V -| Index-W -| Index-X,Y,Z Index C Caffeine in hypotension 848 , 849 sleep disorders with 451t CAGE questionnaire 336-337 Calcidiol...
Lymphoma, non-Hodgkin's, adult: Treatment - Health Professional Information [NCI PDQ] - Quest Diagnostics Patient Health Library
Lymphoma, non-Hodgkin's, adult: Treatment - Health Professional Information [NCI PDQ] This information is produced and provided by the National Cancer Institute (NCI). Although relapse-free survival favored fludarabine (median duration 19 months vs. Nathwani BN, Drachenberg MR, Hernandez AM, et al.: Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
Leukemia, hairy cell: Treatment - Health Professional Information [NCI PDQ] - Quest Diagnostics Patient Health Library
(Refer to the PDQ summary on Levels of Evidence for more information.) Cladribine (2-chlorodeoxyadenosine, 2-CdA) and pentostatin are both highly efficacious in the treatment of patients with disease refractory to interferon alfa.[ 1 , 2 , 3 , 4 ] Rituximab can induce durable complete remissions with minimal toxic effects in the majority of patients with relapsing or refractory...
Leukemia, chronic lymphocytic: Treatment - Health Professional Information [NCI PDQ] - Quest Diagnostics Patient Health Library
These patients demonstrate splenomegaly and poor response to low-dose or high-dose chemotherapy.[ 9 , 22 ] Cladribine (2-chlorodeoxyadenosine) appears to be an active agent (60% complete remission rate) for patients with de novo B-cell prolymphocytic leukemia.[ 23 ][Level of evidence: 3iiiDiii] Alemtuzumab (campath-1H), an anti-CD52 humanized monoclonal antibody, has been used...
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. >" onFocus="javascript:this.value='';"/> About St. Jude Children's Research Hospital 332 N. (in press) Church C, Santana V, Hinds P.-The contested border of “Informal Research” and “Innovative care”: skirmishes over roles, responsibilities & resource...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. >" onFocus="javascript:this.value='';"/> About St. Jude Children's Research Hospital 332 N. (in press) Church C, Santana V, Hinds P.-The contested border of “Informal Research” and “Innovative care”: skirmishes over roles, responsibilities & resource...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. >" onFocus="javascript:this.value='';"/> About St. Jude Children's Research Hospital 332 N. (in press) Church C, Santana V, Hinds P.-The contested border of “Informal Research” and “Innovative care”: skirmishes over roles, responsibilities & resource...
author: St. Jude Children's Research Hospital
A to Z List - Medication Information
A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z - A Abacavir Abacavir, lamivudine, zidovudine Acyclovir Alendronate Allopurinol Amifostine Amitriptyline Amlodipine Amoxicillin Amoxicillin / clavulanic acid Amphotericin B Ampicillin Amprenavir Anti-thymocyte globulin Asparaginase Atenolol Atovaquone Atracurium Azithromycin top - -...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. >" onFocus="javascript:this.value='';"/> About St. Jude Children's Research Hospital 332 N. (in press) Church C, Santana V, Hinds P.-The contested border of “Informal Research” and “Innovative care”: skirmishes over roles, responsibilities & resource...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. >" onFocus="javascript:this.value='';"/> About St. Jude Children's Research Hospital 332 N. (in press) Church C, Santana V, Hinds P.-The contested border of “Informal Research” and “Innovative care”: skirmishes over roles, responsibilities & resource...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. >" onFocus="javascript:this.value='';"/> About St. Jude Children's Research Hospital 332 N. (in press) Church C, Santana V, Hinds P.-The contested border of “Informal Research” and “Innovative care”: skirmishes over roles, responsibilities & resource...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty Charles B. Rodriguez-Galindo C, Radomski K, Stewart C, Furman W, Santana V, Houghton P.-Model de desenvolupament de drogues antineoplastiques en pediatria: traduccio directa del model preclinic a la clinica. Sandlund JT, Murphy SB, Santana VM, Behm F, Jones D, Berard CW...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. >" onFocus="javascript:this.value='';"/> About St. Jude Children's Research Hospital 332 N. (in press) Church C, Santana V, Hinds P.-The contested border of “Informal Research” and “Innovative care”: skirmishes over roles, responsibilities & resource...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. >" onFocus="javascript:this.value='';"/> About St. Jude Children's Research Hospital 332 N. (in press) Church C, Santana V, Hinds P.-The contested border of “Informal Research” and “Innovative care”: skirmishes over roles, responsibilities & resource...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. >" onFocus="javascript:this.value='';"/> About St. Jude Children's Research Hospital 332 N. (in press) Church C, Santana V, Hinds P.-The contested border of “Informal Research” and “Innovative care”: skirmishes over roles, responsibilities & resource...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. >" onFocus="javascript:this.value='';"/> About St. Jude Children's Research Hospital 332 N. (in press) Church C, Santana V, Hinds P.-The contested border of “Informal Research” and “Innovative care”: skirmishes over roles, responsibilities & resource...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty Charles B. Rodriguez-Galindo C, Radomski K, Stewart C, Furman W, Santana V, Houghton P.-Model de desenvolupament de drogues antineoplastiques en pediatria: traduccio directa del model preclinic a la clinica. Sandlund JT, Murphy SB, Santana VM, Behm F, Jones D, Berard CW...
author: St. Jude Children's Research Hospital
Victor M. Santana, MD
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty Charles B. Rodriguez-Galindo C, Radomski K, Stewart C, Furman W, Santana V, Houghton P.-Model de desenvolupament de drogues antineoplastiques en pediatria: traduccio directa del model preclinic a la clinica. Sandlund JT, Murphy SB, Santana VM, Behm F, Jones D, Berard CW...
author: St. Jude Children's Research Hospital
BioPortfolio Limited
Exchange Ticker Symbol 5.5 Historical Stock Prices Graph 5.1 Seronos Historical Stock Prices Jan 2003 to Nov 2003 5.6 Key Financial Information 5.6.1 Product Sales Graph 5.2 Seronos Global Product Sales 1998-2002 Graph 5.3 Seronos Global Product Sales, by Region 2002 5.6.2 Royalty and License Income Graph 5.4 Seronos Royalty and License Income 1998-2002 5.6.3...
BioPortfolio Limited
9 Summary 12 CHAPTER 2 MARKET SEGMENTATION & DEFINITION 23 Strategic scoping and focus 24 Market definition 25 Diagnostic definitions 25 Marketed drugs 27 The gold standard in MS 28 Comparison of key brands 28 Efficacy for reducing relapses 31 Side-effect profile 31 Dosing convenience 31 Storage convenience 32 Cost 32 Patient coverage 32 Marketing strength 33 Overall performance 33...
Database C
C - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products. Product development terminated! Approved by the FDA in September 2001 Catrix® (1496) CAV-6.1 (Candida Albicans Vaccine) (1550)...
2-Chloro-2'-deoxyadenosine - BLG-C028
- - For Pricing Information click here and submit your country BLG-C028 2-Chloro-2'-deoxyadenosine [BioLog] - Main Category: Adenosine Derivatives Related Categories: - General: Product-ID BLG-C028 Product Name 2-Chloro-2'-deoxyadenosine Synonyms Cladribine 2-Cl-dAdo CdA Product Numbers / Sizes: BLG-C028-100 100 µmol - - BLG-C028-500 5x100 µmol - - BLG-C028-1000 10x100 &...
http://www.adis.com/files/newsletters/INP/Icov1435.pdf
20 Salcaprozate sodium enables GI absorption of oral insulin 8 RESPIRATORY MEDICINE GASTROENTEROLOGY Budesonide/ formoterol single inhaler superior in asthma 11 Antibacterials controversial in acute pancreatitis 2 Ciclesonide (intranasal) in seasonal allergic rhinitis 7 Antiulcer coprescribing threatens COX- 2 inhibitor cost savings 5 Ciclesonide approved in the UK 21 Infliximab...
http://www.adis.com/files/newsletters/CT/Ctcov63.pdf
20 Mar 2004 No 63 HIGHLIGHTS Imiquimod: topical therapy hits the spot in BCC 3 Trastuzumab: potential benefit in advanced NSCLC 5 ST 1926 a novel apoptosis- inducing treatment for 7 myeloid leukaemia News & Views Pharmacology Alternative medicine use among cancer patients is Chemotherapy: effect of MTHFR C677T potentially risky 2 polymorphism 8 Imiquimod effective in BCC 3...
http://www.adis.com/files/newsletters/REA/Rxcov991.pdf
16 Dinitrochlorobenzene: contact dermatitis with subsequent 8 Current Issues & Opinions lymphadenosis benigna cutis Licensing trials should record all adverse results and be made 2 Enalapril: angioedema [S] 8 public Enoxaparin sodium: heparin- induced thrombocytopenia 8 Therapeutic drug monitoring identifies medication errors 2 leading to venous thrombosis [S] Adverse Reaction...